Circovirus

• 5 minutes

It’s one of the most devastating and economically damaging pig diseases in the world: Porcine circovirus associated disease (PCVAD). It can strike early or appear in a late form. And once it strikes, the consequences are never good.

• 10 minutes

Ingelheim/Germany, 09 February, 2017 – For the tenth time, Boehringer Ingelheim Animal Health has funded independent European research projects related to Porcine Circovirus Type 2 (PCV2) infection and associated diseases. Over the past ten years, 29 research projects have been awarded with € 25,000.

• 10 minutes

Worldwide over two billion pigs have been protected against Porcine Circovirus Disease using Ingelvac CircoFLEX® 

The vaccine contributes to sustainable production and supply of healthy, nutritious pork around the world like no other vaccine1

• 15 minutes

Grants amounting to €650,000 have been awarded to European projects since 2007 under an annual programme to encourage applied research into the circovirus PCV2 and the disease pictures linked to it.  Decisions on pig health care have changed significantly in Europe over the past decade, regarding the use of vaccination in controlling the diseases associated with the virus known as PCV2. It is an extraordinary story of success that continues to expand as applied research and practical experience give even better insights into the virus itself and the diseases associated with it.